Sunday 18 October 2026
Export BBOT’s income statement to Excel — free account
BridgeBio Oncology Therapeutics, Inc
BBOT Healthcare Biotechnology
In the quarter to June 2026, EPS fell 25.3% and free cash flow fell 88.8%, each against the same quarter a year earlier.
2.82
0.13
−4.41%
Follow BBOT
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '24 | Dec '25 | |
|---|---|---|
Cash and Short Term Investments |
155.63 | 425.46 |
Receivables |
0.08 | 0.39 |
Total current assets |
158.69 | 432.40 |
Property, Plant, Equpment (Net) |
0.49 | 0.96 |
Long-term assets (Other) |
5.12 | 12.70 |
Total non-current assets |
5.61 | 15.99 |
Total Assets |
164.30 | 448.38 |
Accounts Payable |
3.07 | 1.37 |
Accrued Expenses |
12.75 | 32.37 |
Other current liabilities |
3.11 | — |
Total current liabilities |
19.58 | 35.04 |
Preferred Shares of Subsidiary (Mandatory, Redeemable) |
323.36 | — |
Total non-current liabilities |
323.36 | 2.24 |
Total liabilities |
342.94 | 37.29 |
Additional Paid In Capital |
43.54 | 767.64 |
Common Stock (Net) |
— | 0.01 |
Retained Earnings |
(222.52) | (356.57) |
Common Equity (Total) |
(178.64) | 411.10 |
Shareholders Equity (Total) |
(178.64) | 411.10 |
Shareholders Equity and Liabilities (Total) |
164.30 | 448.38 |
Shares (Common) |
0.03 | 79.99 |
Shareholders Equity (Tangible) |
(178.64) | 411.10 |
Net Debt |
(155.63) | (425.46) |
In millions of $ except per-share values · columns are period end dates